| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACETAZOLAMIDE | 211372 | 002 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 250MG | No | No | 2021/02/22 | 2021/02/22 | APPCO | Prescription |
| ACETAZOLAMIDE | 215101 | 001 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 125MG | No | No | 2021/08/19 | 2021/08/19 | RUBICON | Prescription |
| ACETAZOLAMIDE | 215101 | 002 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 250MG | No | No | 2021/08/19 | 2021/08/19 | RUBICON | Prescription |
| ACETAZOLAMIDE | 211069 | 001 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 125MG | No | No | 2023/04/04 | 2023/04/04 | ZYDUS LIFESCIENCES | Prescription |
| ACETAZOLAMIDE | 211069 | 002 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 250MG | No | No | 2023/04/04 | 2023/04/04 | ZYDUS LIFESCIENCES | Prescription |
| ACETAZOLAMIDE | 217197 | 001 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 125MG | No | No | 2023/05/09 | 2023/05/09 | NE RX PHARMA | Prescription |
| ACETAZOLAMIDE | 217197 | 002 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 250MG | No | No | 2023/05/09 | 2023/05/09 | NE RX PHARMA | Prescription |
| ACETAZOLAMIDE | 211151 | 001 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 125MG | No | No | 2023/09/11 | 2023/09/11 | AJANTA PHARMA LTD | Discontinued |
| ACETAZOLAMIDE | 211151 | 002 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 250MG | No | No | 2023/09/11 | 2023/09/11 | AJANTA PHARMA LTD | Discontinued |
| ACETAZOLAMIDE | 213706 | 001 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 125MG | No | No | 2024/01/26 | 2024/01/26 | TORRENT | Discontinued |
| ACETAZOLAMIDE | 213706 | 002 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 250MG | No | No | 2024/01/26 | 2024/01/26 | TORRENT | Discontinued |
| ACETAZOLAMIDE | 218023 | 001 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 125MG | No | No | 2024/05/14 | 2024/05/14 | EPIC PHARMA LLC | Prescription |
| ACETAZOLAMIDE | 218023 | 002 | ANDA | ACETAZOLAMIDE | TABLET;ORAL | 250MG | No | No | 2024/05/14 | 2024/05/14 | EPIC PHARMA LLC | Prescription |